Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 327
6
Diseases
5
Unique genes
0.277
Avg. similarity score
Arthralgia
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Arthralgia
Hyper-immunoglobulin d syndrome
Hyper-igd syndrome
Mevalonate kinase deficiency
Bone marrow neoplasms
methylmalonic aciduria, cblb type
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Arthralgia | 4 | 4 | 2 |
| Hyper-immunoglobulin d syndrome | 4 | 4 | 4 |
| Hyper-igd syndrome | 3 | 3 | 1 |
| Mevalonate kinase deficiency | 3 | 3 | 2 |
| Bone marrow neoplasms | 1 | 1 | 1 |
| methylmalonic aciduria, cblb type | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MVK | 4 / 6 | Arthralgia, Hyper-igd syndrome, Hyper-immunoglobulin d syndrome, Mevalonate kinase deficiency |
| CSF3 | 2 / 6 | Arthralgia, Bone marrow neoplasms |
| HMGCR | 2 / 6 | Hyper-immunoglobulin d syndrome, Mevalonate kinase deficiency |
| MMAB | 2 / 6 | Hyper-immunoglobulin d syndrome, methylmalonic aciduria, cblb type |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cholesterol biosynthesis | Reactome | 2 / 21 | 229× | 2.90e-5 | 8.11e-4 ✓ sig. |
| Terpenoid backbone biosynthesis | KEGG | 2 / 23 | 209× | 3.50e-5 | 9.50e-4 ✓ sig. |
| Activation of gene expression by SREBF (SREBP) | Reactome | 2 / 42 | 114× | 1.19e-4 | 2.57e-3 ✓ sig. |
| Defective MMAB causes methylmalonic aciduria type cblB | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 6.90e-3 ✓ sig. |
| Cobalamin transport and metabolism | KEGG | 1 / 18 | 133× | 7.47e-3 | 5.69e-2 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | Reactome | 1 / 20 | 120× | 8.30e-3 | 6.10e-2 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | Reactome | 1 / 21 | 114× | 8.71e-3 | 6.31e-2 |
| Other interleukin signaling | Reactome | 1 / 24 | 100× | 9.95e-3 | 6.82e-2 |
| Metabolic pathways | KEGG | 3 / 1,563 | 4.6× | 1.79e-2 | 9.70e-2 |
| Porphyrin metabolism | KEGG | 1 / 46 | 52.2× | 1.90e-2 | 9.99e-2 |
| Interleukin-10 signaling | Reactome | 1 / 47 | 51.1× | 1.94e-2 | 1.01e-1 |
| Malaria | KEGG | 1 / 50 | 48.0× | 2.06e-2 | 1.05e-1 |
| Peroxisome | KEGG | 1 / 83 | 28.9× | 3.41e-2 | 1.39e-1 |
| Bile secretion | KEGG | 1 / 90 | 26.7× | 3.69e-2 | 1.45e-1 |
| IL-17 signaling pathway | KEGG | 1 / 94 | 25.6× | 3.85e-2 | 1.48e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| isoprenoid biosynthetic process | GO:0008299 | 2 / 13 | 575× | 4.46e-6 | 2.74e-4 ✓ sig. |
| sterol biosynthetic process | GO:0016126 | 2 / 31 | 241× | 2.66e-5 | 1.11e-3 ✓ sig. |
| cholesterol biosynthetic process | GO:0006695 | 2 / 39 | 192× | 4.23e-5 | 1.59e-3 ✓ sig. |
| steroid biosynthetic process | GO:0006694 | 2 / 65 | 115× | 1.18e-4 | 3.43e-3 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 2 / 107 | 69.9× | 3.21e-4 | 7.03e-3 ✓ sig. |
| steroid metabolic process | GO:0008202 | 2 / 135 | 55.4× | 5.11e-4 | 9.70e-3 ✓ sig. |
| isopentenyl diphosphate biosynthetic process, mevalonate pathway | GO:0019287 | 1 / 3 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| positive regulation of myeloid cell differentiation | GO:0045639 | 1 / 5 | 747× | 1.34e-3 | 1.79e-2 ✓ sig. |
| coenzyme A metabolic process | GO:0015936 | 1 / 5 | 747× | 1.34e-3 | 1.79e-2 ✓ sig. |
| granulocyte colony-stimulating factor signaling pathway | GO:0038158 | 1 / 5 | 747× | 1.34e-3 | 1.79e-2 ✓ sig. |
| cobalamin metabolic process | GO:0009235 | 1 / 9 | 415× | 2.41e-3 | 2.50e-2 ✓ sig. |
| regulation of SNARE complex assembly | GO:0035542 | 1 / 12 | 311× | 3.21e-3 | 2.91e-2 ✓ sig. |
| negative regulation of amyloid-beta clearance | GO:1900222 | 1 / 12 | 311× | 3.21e-3 | 2.91e-2 ✓ sig. |
| regulation of actin filament organization | GO:0110053 | 1 / 13 | 287× | 3.47e-3 | 3.06e-2 ✓ sig. |
| protein targeting to vacuole | GO:0006623 | 1 / 14 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hyper-immunoglobulin d syndrome | Mevalonate kinase deficiency | 0.400 | 2 | 5.06e-8 | 3.92e-7 ✓ sig. |
| Arthralgia | Hyper-igd syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Arthralgia | Bone marrow neoplasms | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Hyper-igd syndrome | Mevalonate kinase deficiency | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Arthralgia | Mevalonate kinase deficiency | 0.250 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Hyper-igd syndrome | Hyper-immunoglobulin d syndrome | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Hyper-immunoglobulin d syndrome | methylmalonic aciduria, cblb type | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Arthralgia | Hyper-immunoglobulin d syndrome | 0.167 | 1 | 5.19e-4 | 1.04e-3 ✓ sig. |